- Certain types of advanced thyroid cancer
- Advanced Liver cancer
- Certain types of kidney cancer
- Endometrial cancer
Lenvalieva 10mg
| MRP | : |
|
| Price | : | ₹4,200.00 |
| You Save | : | ₹4,893.75 (53.81%) |
30 Capsule(s) In A Bottle
Lenvalieva 10mg Capsule contains the active ingredient Lenvatinib. This medication is a tyrosine kinase inhibitor used for progressive or advanced thyroid cancer when radioactive iodine therapy is ineffective. Additionally, it is prescribed for liver cancer patients who have not received prior treatment and are not candidates for surgical intervention.
Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) typically manifests in individuals over 60 years old. Symptoms include an enlarged and hardened thyroid gland, along with voice hoarseness resulting from nerve paralysis in the larynx. Hepatocellular carcinoma (liver cancer) arises from existing liver issues such as cirrhosis or chronic hepatitis B infection. Individuals with a history of allergic reactions to Lenvalieva 10mg Capsule or any of its ingredients should avoid this medication. Furthermore, patients must notify their dentist or oral surgeon about their use of Lenvalieva 10mg Capsule, as it may hinder wound healing and elevate the risk of bleeding.
